- Home
- WALD vs OLMA Comparison
WALD vs OLMA Comparison
Compare WALD & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- OLMA
- Stock Information
- Founded
- WALD 1988
- OLMA 2006
- Country
- WALD United States
- OLMA United States
- Employees
- WALD N/A
- OLMA N/A
- Industry
- WALD Package Goods/Cosmetics
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- OLMA Health Care
- Exchange
- WALD Nasdaq
- OLMA Nasdaq
- Market Cap
- WALD 306.3M
- OLMA 378.9M
- IPO Year
- WALD 2021
- OLMA 2020
- Fundamental
- Price
- WALD $1.56
- OLMA $5.46
- Analyst Decision
- WALD Strong Buy
- OLMA Strong Buy
- Analyst Count
- WALD 5
- OLMA 5
- Target Price
- WALD $4.96
- OLMA $24.00
- AVG Volume (30 Days)
- WALD 528.0K
- OLMA 450.7K
- Earning Date
- WALD 11-11-2025
- OLMA 08-11-2025
- Dividend Yield
- WALD N/A
- OLMA N/A
- EPS Growth
- WALD N/A
- OLMA N/A
- EPS
- WALD N/A
- OLMA N/A
- Revenue
- WALD $273,868,000.00
- OLMA N/A
- Revenue This Year
- WALD $10.37
- OLMA N/A
- Revenue Next Year
- WALD $14.37
- OLMA N/A
- P/E Ratio
- WALD N/A
- OLMA N/A
- Revenue Growth
- WALD 25.55
- OLMA N/A
- 52 Week Low
- WALD $1.50
- OLMA $2.86
- 52 Week High
- WALD $4.40
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- WALD 35.98
- OLMA 54.42
- Support Level
- WALD $1.50
- OLMA $5.54
- Resistance Level
- WALD $1.79
- OLMA $5.85
- Average True Range (ATR)
- WALD 0.16
- OLMA 0.30
- MACD
- WALD 0.00
- OLMA -0.01
- Stochastic Oscillator
- WALD 10.00
- OLMA 51.79
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.